Skip to main content
Mohammad Eslami, MD, Vascular Surgery, Pittsburgh, PA, UPMC Magee-Womens Hospital

MohammadHEslamiMDMPH

Vascular Surgery Pittsburgh, PA

Professor of Surgery University of Pittsburgh Medical School Chief of Vascular Surgery UPMC Mercy

Dr. Eslami is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Eslami's full profile

Already have an account?

Summary

  • Dr. Mohammad Eslami is a vascular surgeon in Pittsburgh, PA and is affiliated with multiple hospitals in the area, including UPMC Magee-Womens Hospital, UPMC Mercy, UPMC Presbyterian, and UPMC Altoona. He received his medical degree from Harvard Medical School and has been in practice 26 years. He is experienced in peripheral vascular disease, carotid disease, aortic surgery, endovascular surgery, and aortic disease.

Education & Training

  • Boston University School of Public Health
    Boston University School of Public HealthMPH, Biostatistics, 2013 - 2016
  • Stony Brook Medicine/University Hospital
    Stony Brook Medicine/University HospitalFellowship, Vascular Surgery, 1999 - 2001
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Surgery, 1993 - 1998
  • University of Chicago
    University of ChicagoResidency, Surgery, 1991 - 1993
  • Harvard Medical School
    Harvard Medical SchoolClass of 1991

Certifications & Licensure

  • WV State Medical License
    WV State Medical License 2023 - 2024
  • MA State Medical License
    MA State Medical License 1993 - 2024
  • PA State Medical License
    PA State Medical License 2001 - 2024
  • NY State Medical License
    NY State Medical License 1999 - 2001
  • American Board of Surgery Vascular Surgery

Awards, Honors, & Recognition

  • Fellow (FACC) American College of Cardiology, 2012
  • Fellow (FACS) American College of Surgeons

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Risk Factors for Mortality After Endovascular Repair for Traumatic Thoracic Aortic Injury  
    Abhisekh Mohapatra, Nathan L Liang, Marc L Schermerhorn, Alik Farber, Mohammad H Eslami, Journal of Vascular Surgery
  • Nationwide Trends in Drug-Coated Balloon and Drug-Eluting Stent Utilization in the Femoropopliteal Arteries  
    Abhisekh Mohapatra, Daniel J Bertges, Michael C Madigan, Georges E Al-Khoury, Mohammad H Eslami, Journal of Vascular Surgery
  • Risk Factors for Perioperative Mortality After Revascularization for Acute Aortic Occlusion  
    Abhisekh Mohapatra, Karim M Salem, Efthymios D Avgerinos, Mohammad H Eslami, Journal of Vascular Surgery
  • Join now to see all

Authored Content

  • Risk Factors for Mortality After Endovascular Repair for Traumatic Thoracic Aortic InjuryJuly 2018
  • Nationwide Trends in Drug-Coated Balloon and Drug-Eluting Stent Utilization in the Femoropopliteal ArteriesJuly 2018
  • IP029. Incorporating Patient and Anatomic Factors in Predicting Operative Mortality of Abdominal Aortic Aneurysm Repair: A Robust Risk Score CalculatorMay 2018
  • IP029. Incorporating Patient and Anatomic Factors in Predicting Operative Mortality of Abdominal Aortic Aneurysm Repair: A Robust Risk Score CalculatorMay 2018
  • RS03. Tapered Arteriovenous Grafts Do Not Provide Significant Advantage over Nontapered Grafts in Upper Extremity Dialysis AccessMay 2018
  • RS03. Tapered Arteriovenous Grafts Do Not Provide Significant Advantage over Nontapered Grafts in Upper Extremity Dialysis AccessMay 2018
  • Emergency Department Utilization After Lower Extremity Bypass for Critical Limb IschemiaMay 2018
  • Emergency Department Utilization After Lower Extremity Bypass for Critical Limb IschemiaMay 2018
  • Guidelines for Hospital Privileges in Vascular Surgery and Endovascular Interventions: Recommendations of the Society for Vascular SurgeryApril 2018
  • Implementation of Drug-Eluting Stents for the Treatment of Femoropopliteal Disease Provides Significant Cost-to-System Savings in a Single-State Outpatient SimulationFebruary 2018
  • Implementation of Drug-Eluting Stents for the Treatment of Femoropopliteal Disease Provides Significant Cost-to-System Savings in a Single-State Outpatient SimulationFebruary 2018
  • Implementation of Drug-Eluting Stents for the Treatment of Femoropopliteal Disease Provides Significant Cost-to-System Savings in a Single-State Outpatient SimulationFebruary 2018
  • Intraoperative Heparin Use for Upper Extremity Arteriovenous Access Creation Does Not Affect OutcomesJanuary 2018
  • Intraoperative Heparin Use for Upper Extremity Arteriovenous Access Creation Does Not Affect OutcomesJanuary 2018
  • Join now to see all

Professional Memberships

Hospital Affiliations